Categories: Artificial IntelligenceDataHealthTechLearnManagementMedtechPlatformResearchSoftwareTime
We harmonize, standardize and analyze multimodal healthcare data to enable the right decisions sooner in healthcare.
Investors 2
Funding Rounds 2
| Date | Series | Amount | Investors |
| 16.10.2024 | Series B | $8M | - |
| 02.05.2024 | Series A | $6.18M | - |
Mentions in press and media 5
| Date | Title | Description |
| 17.10.2024 | Mars Petcare's Leadership Shake-Up: A New Era for Veterinary Health and Diagnostics | In a bold move, Mars Petcare has reshuffled its leadership deck, signaling a fresh chapter for its Veterinary Health and Science & Diagnostics divisions. This change comes as the company, a titan in the pet care industry, seeks to innov... |
| 16.10.2024 | Ikerian Secures USD 8 Million in Series B funding to expand RetinAI discovery across Europe | Ikerian (former RetinAI) and its subsidiary, RetinAI U.S. Inc. a leading developer of software solutions for medical image and data management, and artificial intelligence (AI) in healthcare, announced today the successful first close of it... |
| 16.10.2024 | Ikerian Holds Series B Funding First Close of USD 8M | (left) Carlos Ciller, PhD, CEO, co-founder and Chairman Ikerian AG and RetinAI US Inc.; (center) Stefanos Apostolopoulos, PhD, CTO and co-founder Ikerian AG and RetinAI US Inc.; (right) Sandro De Zanet, PhD, Chief Scientific Officer and co-... |
| 16.10.2024 | USD 8M and a strategic partner for Ikerian AG |
Ikerian AG and its subsidiary, RetinAI U.S. Inc. are committed to revolutionizing the way ophthalmology clinics connect and manage patient data. Established in 2017, the company develops software solutions to accelerate clinical, research ... |
| 02.05.2024 | Ikerian Closes USD 6.18M Series A Extension Financing | (left) Carlos Ciller, PhD, CEO, co-founder and Chairman Ikerian AG and RetinAI US Inc.; (center) Stefanos Apostolopoulos, PhD, CTO and co-founder Ikerian AG and RetinAI US Inc.; (right) Sandro De Zanet, PhD, Chief Scientific Officer and co-... |
Reviews 0
